Clinical Trial Update: Driving Simulation to Assess Non-Sedative Effects of Tolperisone [Phase 1]

View source ↗

Summary

Phase 1 trial examining non-sedative effects of tolperisone on driving performance; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Driving Impairment

Drugs mentioned

• Tolperisone (tolperisone)

Snippet

Sponsor: Neurana Pharmaceuticals, Inc. | Conditions: Driving Impaired | Phase 1 | Status: COMPLETED | Results posted: 2020-10-20